A recent study in patients with pancreatic ductal adenocarcinoma observed markedly decreased apoA-IV concentrations in plasma but a pronounced increase of mRNA in the diseased pancreatic tissue which was linked with a less favourable outcome of the patients. This evidence concerns the gene APOA4 and pancreatic ductal adenocarcinoma.